Molecular detection and analysis firm Oxford Nanopore Technologies has raised £40m ($64m) in private equity funding from new and existing backers.

Founded in 2005, the firm is commercialising a DNA sequencing system which utilises nanopores originally developed at the University of Oxford. Its technologies can be used in DNA sequencing, diagnostics, drug development, biomolecular interaction, and defence applications.

The latest round of funding brings the total amount raised by the company to £145m. Investors in the company include venture firm…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?